Biogen | BIIB - Валовая прибыль

Биржевая цена
190.45
Изменение за день
-3.93 -2.02%
Ежемесячно
3.88%
Ежегодный
57.49%
Q2 прогноз
180.43




Валовая прибыль Изменить Дата
AbbVie USD 12.54B 474M 2026-03
Acadia Pharmaceuticals USD 257.76M 778K 2025-12
ALKERMES USD 338.34M 72.51M 2025-12
Amgen USD 6.89B 415M 2025-12
Bayer EUR 5.35B 1.02B 2025-09
Biogen USD 1.82B 169.5M 2026-03
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Eli Lilly USD 15.92B 1.33B 2025-12
Esperion Therapeutics USD 140.59M 94.57M 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
Incyte USD 1.17B 217.51M 2026-03
Merck USD 10.85B 2.57B 2025-12
Moderna USD 226M 583M 2025-12
Neurocrine Biosciences USD 787.9M 7M 2025-12
Novartis USD 10.25B 570M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
PTC Therapeutics USD 148.38M 39.31M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Sangamo BioSciences -2.39M 1.09M 2024-06
Sanofi EUR 8.45B 1.31B 2025-12
Sanofi EUR 8.45B 3.02B 2025-12
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
Teva Pharmaceutical Industries USD 2.11B 547M 2026-03
Ultragenyx Pharmaceutical USD 178M 46.06M 2025-12
United Therapeutics USD 315.5M 286.6M 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12